SG11201407967TA - Oligonucleotide synthesis method using highly dispersible liquid-phase support - Google Patents

Oligonucleotide synthesis method using highly dispersible liquid-phase support

Info

Publication number
SG11201407967TA
SG11201407967TA SG11201407967TA SG11201407967TA SG11201407967TA SG 11201407967T A SG11201407967T A SG 11201407967TA SG 11201407967T A SG11201407967T A SG 11201407967TA SG 11201407967T A SG11201407967T A SG 11201407967TA SG 11201407967T A SG11201407967T A SG 11201407967TA
Authority
SG
Singapore
Prior art keywords
synthesis method
acid
phase support
hydrophobic
highly dispersible
Prior art date
Application number
SG11201407967TA
Other languages
English (en)
Inventor
Shokaku Kim
Masanori Matsumoto
Original Assignee
Hokkaido System Science Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hokkaido System Science Co Ltd filed Critical Hokkaido System Science Co Ltd
Publication of SG11201407967TA publication Critical patent/SG11201407967TA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • C07H1/02Phosphorylation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • C07H1/02Phosphorylation
    • C07H1/04Introducing polyphosphoric acid radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • C07H19/073Pyrimidine radicals with 2-deoxyribosyl as the saccharide radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/02Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SG11201407967TA 2012-05-30 2012-05-30 Oligonucleotide synthesis method using highly dispersible liquid-phase support SG11201407967TA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2012/063921 WO2013179412A1 (ja) 2012-05-30 2012-05-30 高分散性液相支持体を用いたオリゴヌクレオチド合成法

Publications (1)

Publication Number Publication Date
SG11201407967TA true SG11201407967TA (en) 2015-01-29

Family

ID=49672666

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201407967TA SG11201407967TA (en) 2012-05-30 2012-05-30 Oligonucleotide synthesis method using highly dispersible liquid-phase support

Country Status (7)

Country Link
US (1) US9284344B2 (enrdf_load_html_response)
EP (1) EP2857412B1 (enrdf_load_html_response)
DK (1) DK2857412T3 (enrdf_load_html_response)
IL (1) IL235978B (enrdf_load_html_response)
IN (1) IN2014DN10144A (enrdf_load_html_response)
SG (1) SG11201407967TA (enrdf_load_html_response)
WO (1) WO2013179412A1 (enrdf_load_html_response)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0923225A2 (pt) 2008-12-02 2016-10-04 Chiralgen Ltd metodo para sintese de acidos nucleicos modificados no atomo de fosforo
SG177564A1 (en) 2009-07-06 2012-02-28 Ontorii Inc Novel nucleic acid prodrugs and methods of use thereof
JP5868324B2 (ja) 2010-09-24 2016-02-24 株式会社Wave Life Sciences Japan 不斉補助基
KR20140068884A (ko) 2011-07-19 2014-06-09 웨이브 라이프 사이언시스 피티이. 리미티드 관능화된 핵산의 합성 방법
CN106977567B (zh) * 2012-02-17 2021-02-02 味之素株式会社 碱基部保护寡核苷酸
US8846885B2 (en) 2012-02-17 2014-09-30 Ajinomoto Co., Inc. Oligonucleotide with protected base
PL2872147T3 (pl) 2012-07-13 2023-09-25 Wave Life Sciences Ltd. Sposób wytwarzania chiralnych oligonukleotydów
CN104684893B (zh) 2012-07-13 2016-10-26 日本波涛生命科学公司 不对称辅助基团
AU2013287630B2 (en) 2012-07-13 2017-05-25 Shin Nippon Biomedical Laboratories, Ltd. Chiral nucleic acid adjuvant
US10144933B2 (en) 2014-01-15 2018-12-04 Shin Nippon Biomedical Laboratories, Ltd. Chiral nucleic acid adjuvant having immunity induction activity, and immunity induction activator
JPWO2015108046A1 (ja) 2014-01-15 2017-03-23 株式会社新日本科学 抗アレルギー作用を有するキラル核酸アジュバンド及び抗アレルギー剤
JPWO2015108048A1 (ja) 2014-01-15 2017-03-23 株式会社新日本科学 抗腫瘍作用を有するキラル核酸アジュバンド及び抗腫瘍剤
BR112016016400A2 (pt) 2014-01-16 2017-10-03 Wave Life Sciences Ltd Composições de oligonucleotídeos quiralmente controlados, seu uso, sua composição farmacêutica, e métodos
TWI729028B (zh) 2015-11-17 2021-06-01 日商日產化學工業股份有限公司 寡核苷酸的製造方法
WO2017104836A1 (ja) * 2015-12-16 2017-06-22 味の素株式会社 オリゴヌクレオチドの製造方法、およびヌクレオシド、ヌクレオチドまたはオリゴヌクレオチド
JPWO2017111137A1 (ja) * 2015-12-22 2018-10-18 味の素株式会社 オリゴヌクレオチドの製造方法
CN113423715A (zh) 2019-02-15 2021-09-21 味之素株式会社 寡核苷酸的制造方法
JP7628073B2 (ja) 2019-02-28 2025-02-07 富士フイルム株式会社 ペプチド化合物の製造方法、保護基形成用試薬、及び、芳香族複素環化合物
WO2020196890A1 (ja) 2019-03-28 2020-10-01 味の素株式会社 ホスホロチオエート化部位を有するオリゴヌクレオチドの製造方法
CN114206897B (zh) * 2019-05-08 2024-09-20 比奥根Ma公司 寡核苷酸的汇聚液相合成
WO2021039935A1 (ja) * 2019-08-29 2021-03-04 富士フイルム株式会社 核酸化合物の製造方法、及び、核酸化合物
EP4126894A1 (en) 2020-03-31 2023-02-08 Janssen BioPharma, Inc. Synthesis of oligonucleotides and related compounds
FR3111896A1 (fr) * 2020-06-24 2021-12-31 Strainchem Procédés de synthèses en solution de macromolécules à partir d’unités de dérivés de glucides
CN113583069B (zh) * 2021-09-09 2023-06-06 北京大学 核苷磷脂类化合物及其化学合成方法和在核酸递送中的应用
WO2024083746A1 (en) 2022-10-17 2024-04-25 Bachem Holding Ag Method and composition for oligonucleotide synthesis
US12180140B2 (en) 2022-12-23 2024-12-31 Hongene Biotech Corporation Compounds and methods for liquid phase oligonucleotide synthesis
WO2025082632A1 (en) 2023-10-16 2025-04-24 Bachem Holding Ag Method and composition for oligonucleotide synthesis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7094943B2 (en) 1998-04-27 2006-08-22 Hubert Köster Solution phase biopolymer synthesis
JP2003002895A (ja) * 2001-05-30 2003-01-08 Tokyo Inst Of Technol 核酸の合成法
JP4963665B2 (ja) 2007-11-27 2012-06-27 株式会社ミツバ 扁平型コミュテータ及びその製造方法
JP5548852B2 (ja) 2009-05-29 2014-07-16 国立大学法人東京農工大学 疎水性基結合ヌクレオシド、疎水性基結合ヌクレオシド溶液、及び疎水性基結合オリゴヌクレオチド合成方法
CN103476784B (zh) 2011-05-17 2017-05-24 味之素株式会社 制备寡核苷酸的方法
CN106977567B (zh) * 2012-02-17 2021-02-02 味之素株式会社 碱基部保护寡核苷酸

Also Published As

Publication number Publication date
IN2014DN10144A (enrdf_load_html_response) 2015-08-21
EP2857412A1 (en) 2015-04-08
IL235978B (en) 2018-02-28
US9284344B2 (en) 2016-03-15
IL235978A0 (en) 2015-02-01
WO2013179412A1 (ja) 2013-12-05
DK2857412T3 (en) 2017-04-03
US20150112053A1 (en) 2015-04-23
EP2857412B1 (en) 2017-01-11
EP2857412A4 (en) 2015-10-21

Similar Documents

Publication Publication Date Title
SG11201407967TA (en) Oligonucleotide synthesis method using highly dispersible liquid-phase support
SG11201808721YA (en) Cell-free production of ribonucleic acid
SG11201806400XA (en) Replicative transposon system
SG11201900635QA (en) Chimeric antigen receptors targeting bcma and methods of use thereof
SG11201809522WA (en) Method of nucleic acid sequence determination
SG11201807252QA (en) Anti-lag-3 antibodies
SG11201808622SA (en) Chimeric receptors to flt3 and methods of use thereof
SG11201908325PA (en) Process for the preparation of glucuronide drug-linkers and intermediates thereof
SG11201909710XA (en) Indole ahr inhibitors and uses thereof
SG11201804997XA (en) Process for preparing non-cariogenic, sustained energy release juice
SG11201901715UA (en) Adenovirus armed with bispecific t cell engager (bite)
SG11201803169WA (en) Cellulase variants and polynucleotides encoding same
SG11201901077RA (en) Anti-tigit antibodies, anti-pvrig antibodies and combinations thereof
SG11201809344QA (en) Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehyde
SG11201810600WA (en) Fxr (nr1h4) modulating compounds
SG11201808457PA (en) Icos ligand variant immunomodulatory proteins and uses thereof
SG11201810605UA (en) Selectively altering microbiota for immune modulation
SG11201807187XA (en) Binding members to pd-l1
SG11201900772YA (en) Gene editing of car-t cells for the treatment of t cell malignancies with chimeric antigen receptors
SG11201404936YA (en) Channel plate heat transfer system
SG11201908899WA (en) An alcoholic beverage
SG11201903329WA (en) Method for preparing electrocompetent yeast cells, and method for using said cells
SG11201805166PA (en) Light-mediated polymerase chain reaction amplification and product detection system and methods of use
SG11201406438WA (en) Alkoxylation catalyst, method for producing catalyst, and method for producing fatty acid alkyl ester alkoxylate using catalyst
SG11201407117TA (en) Composition for repairing cartilage tissue, method for producing same, and use thereof